{"denoms":[{"counts":[{"groupId":"OG000","value":"0"}],"units":"Participants"}],"groups":[{"description":"This is a treatment guideline for HLA-Haploidentical hematopoietic stem cell transplant (HSCT) using a reduced intensity conditioning (RIC) regimen. This regimen consists of fludarabine, cyclophosphamide and low dose total body irradiation (TBI).\n\nFludarabine: Fludarabine 30 mg/m2 IV over 30-60 minutes on days -6 through -2 before transplant.\n\nCyclophosphamide: Cyclophosphamide 14.5 mg/kg IV over 1-2 hours on days -6 and -5 before transplant and Cyclophosphamide 50 mg/kg IV on days 3 and 4 post-transplant.\n\nTotal Body Irradiation: TBI 200cGy on day -1 before transplant.\n\nHaploidentical stem cell transplant: Non-T-cell depleted bone marrow infusion","id":"OG000","title":"Haploidentical Stem Cell Transplant"}],"populationDescription":"Data were not collected for this Outcome Measure as both participants died by the 6 month time point","reportingStatus":"POSTED","timeFrame":"1 year","title":"Number of Patients Experiencing Chronic Graft-versus-host Disease by 1 Year","type":"SECONDARY"}